Abstract-The impact of size-fractionated colloidal organic carbon (COC) originating from a biological wastewater treatment facility on the sensitivity of the yeast estrogen screen (YES) bioassay containing the human estrogen receptor (hER) gene was evaluated. Dose-response curves of serially diluted 17␤-estradiol (E2), both in the presence and absence of COC, were generated by the YES bioassay. The concentration of E2 leading to a 50% YES response (effective concentration 50%, or EC50) was used to evaluate quantitatively the estrogenic activity of the different COC-E2 mixtures. The EC50 values for all COC size fractions, including COC-free samples (Ͻ1 kD), were statistically greater than the controls using Milli-Q water. Normalized EC50 values significantly increased as a function of COC concentration for the larger size fractions (Ͼ0.22 m), but were not significantly affected by smaller COC material at environmental levels (1-5 mg/L), while both colloidal polysaccharide concentrations and colloidal fluorophores (measured at an excitation/emission wavelength pair of 350 nm/450 nm) appear to have an important role in the sensitivity of the YES bioassay. Estimates of the colloid-associated E2 fraction did not predict accurately increases in EC50 values. Matrix effects of the specific environment being tested with the YES bioassay need to be evaluated closely due to the sensitivity of the hER and reporter plasmid.
INTRODUCTION
The presence of hermaphrodite fish in wastewater treatment lagoons led Purdom et al. [1] to hypothesize that estrogenic compounds both were present and active biologically in treated wastewater. These authors demonstrated that male fish were producing significant concentrations of vitellogenin, a female protein used for egg yolk development, when exposed to wastewater effluents. This study generated worldwide interest about the presence and effect of natural and anthropogenic chemicals that can modulate and/or disrupt the endocrine system of wildlife and humans. Identifying and quantifying estrogenic endocrine-disrupting compounds (EEDCs) in treated effluents has remained a research priority, an effort warranted by reports of widespread sexual disruption of fish in receiving waters [2] [3] [4] and potential negative impact on human health [5, 6] . The major EEDCs found in wastewater effluents include natural and synthetic hormones [7] [8] [9] [10] such as 17␤-estradiol (E2), 17␣-ethinylestradiol (EE2), and estrone and industrial surfactant metabolites [11, 12] including nonylphenol and octylphenol. The majority of estrogenic activity in treated effluents is thought to be caused by E2 and EE2 [9, 13] , although high effluent concentrations of nonylphenol also have resulted in sexual disruption of wildlife [2] .
Both chemical and biological methods have been developed to identify and quantify EEDC concentration and activity in various environments. Biological methods include in vitro bioassays, such as the yeast estrogen screen (YES) using a recombinant yeast strain (Saccharomyces cerevisiae) containing the human estrogen receptor (hER) [14] , or in vivo studies using a model sentinel species [15] . Several investigators have used both chemical analysis and the YES bioassay to inves-* To whom correspondence may be addressed (nlove@vt.edu).
tigate EEDCs present in raw sewage, treated effluents, and receiving waters [11, [16] [17] [18] [19] . This combined analytical approach is helpful when comparing theoretical to measured estrogenic activity (EA). Theoretical EA is determined by calculating the product of EEDC concentration (determined by trace chemical analysis) and its specific estradiol equivalency factor [19] for each EEDC measured and adding them to generate the total theoretical EA. Measured EA is calculated from the YES assay through corrected absorbance readings, and typically is expressed as estradiol equivalents as determined from a dose-response curve of serially diluted E2. Implicitly, the theoretical versus measured EA comparison assumes the absence of any compounds that may interfere with either analysis method.
Based on the literature, the results of theoretical versus measured EA comparison appear somewhat mixed; several investigators report good agreement between the two methods [17, 20] , and others have reported both greater [16, 19] and lower [18] measured EA values compared to theoretical calculations. The authors of these studies have suggested various reasons for their reported discrepancies, including unknown estrogenic-like compounds [18] , estrogen receptor antagonists and/or interaction [18, 19] , yeast inhibitors [21] , and loss of analyte during sample preparation [19] .
Another possible cause of a reduction in measurable EA may be due to sample matrix effects on the YES bioassay, an observation first reported by Tanghe et al. [11] . These authors found that the presence of 150 mg/L humic acid in the growth medium reduced the sensitivity of the YES bioassay to E2 and nonylphenol, as evidenced by a right-shift of the dose-response curves. Tanghe et al. [11] suggested that humic acid was binding with E2 and reducing its bioavailability and/or binding directly to the hER. Similarly, Yamamoto et al. [22] reported that the presence of dissolved organic material reduced the partition coefficient between E2 and synthetic membrane vesicles, primarily due to competition between the dissolved organic material and vesicle for E2. Recently, Tashiro et al. [23] reported that a size exclusion chromatography sample clean-up procedure was necessary for obtaining consistent YES results from river water samples that had been concentrated by solid-phase extraction. Extraction and concentration techniques routinely used for EEDC investigation inadvertently may concentrate materials that reduce the ultimate expression or sensitivity of the YES bioassay.
In an earlier investigation, we demonstrated that colloidal organic carbon (COC) derived from a biological wastewater treatment facility has the ability to sorb E2 [24] . In the current study, we attempt to build upon the work of Tanghe et al. [11] by evaluating the response of the YES bioassay in the presence of COC. The effects of various concentrations, components, and size fractions of COC on E2 bioavailability were evaluated by comparing dose-response curves generated by the YES bioassay. Correlations between E2 bioavailability and components of the COC are presented, and factors that may influence the generated dose-response curves are discussed.
MATERIALS AND METHODS

Experimental approach
We exposed aliquots of mixed liquor suspended solids (MLSS)-derived COC and known concentrations of E2 to the YES bioassay and compared dose-response curves. Four parameters describe a typical dose-response curve, including minimum absorbance, maximum absorbance, slope, and the EC50 value (Fig. 1) . In evaluating toxicity data, it is customary to compare EC50 values (in this case, the concentration of E2 that is halfway between the minimum and maximum absorbance readings) to determine the relative potency of contaminants [25, 26] . The EC50 concentrations were compared using the same contaminant (E2) in the presence of various COC size fractions and COC concentrations. An increase in EC50 indicates that a higher concentration of E2 is needed to affect the same degree of YES expression. For example, in the hypothetical dose-response curves depicted in Figure 1 , a single chemical is added to the YES bioassay incubated in the presence of a defined (e.g., size and concentration) COC fraction. All other conditions being equal, and observing that EC50-2 is greater than EC50-1, we would conclude that sample 2 reduces the apparent estrogenicity of the spiked chemical to a greater degree than sample 1.
Facility overview
Samples were collected from the west aeration basin of the Blacksburg-Virginia Polytechnic Institute and State University (VPI & SU) Sanitation Authority Stroubles Creek Wastewater Treatment Plant (WWTP). This WWTP primarily receives domestic sewage, though the strength depends heavily on the presence or absence of the transient student population. The process flow scheme included primary clarifiers, anoxic and aerobic bioreactors, and secondary clarifiers for liquid-solid separation. The mean cell residence time during the sampling period was approximately 12 d, and MLSS concentrations averaged approximately 1,600 mg/L.
Sample collection, preparation, and size fractionation
Four separate grab samples were collected from the west basin of the aerobic bioreactor between January and May 2003. During each sampling period, approximately 5 L of MLSS were collected in glass bottles, which had been cleaned and rinsed in hot tap water, soaked in 1 M NaOH (minimum 1 h), rinsed in Milli-Q water (Bedford, MA, USA), rinsed in ethanol, and thoroughly rinsed again in Milli-Q water. Samples were transported from the WWTP to the laboratory within 15 min of collection, and the MLSS was allowed to settle for another 45 min for a total settling time of 1 h. The MLSS supernatant was decanted into a similarly cleaned glass container and aliquoted for bulk chemical analysis. Approximately 2 L of supernatant was transferred to a glass filtration apparatus and filtered through precombusted 1.5-m glass fiber filters (Whatman 934-AH, Florham Park, NJ, USA). Aliquots of the Ͻ1.5-m filtrate were used for further size fractionation by using 0.22 m cellulose nitrate disc filters (Fisher, Pittsburgh, PA, USA) and ultrafilter membranes, in parallel, to yield a total of six COC solutions (unfiltered supernatant and five size fractions defined as Ͻ1.5 m, Ͻ0.22 m, Ͻ100 kD, Ͻ30 kD, and Ͻ10 kD). These COC solutions were used in the YES assay experiments. In addition, a Ͻ1-kD solution was prepared and is defined as colloid-free, or truly dissolved.
The 0.22-m disc filters were conditioned with approximately 10 ml of Ͻ1.5-m filtrate prior to producing the Ͻ0.22 m filtrate. Amicon (Billercia, MA, USA) YM100, YM30, and YM10 and YM1 ultrafilters with nominal molecular weight unit cut-offs of 100, 30, 10, and 1 kD, respectively, were used in these experiments. Prior to using the ultrafilters, each membrane was soaked for 1 h in distilled water that was changed three times, soaked overnight at 4ЊC, and finally flushed with 200 ml of Milli-Q water to remove the glycerine preservative added by the manufacturer. All ultrafiltration experiments were conducted in magnetically stirred batch cells (200-ml volume), pressurized with nitrogen gas (350 kPa), stirred at approximately 300 rpm, and operated at room temperature (23ЊC Ϯ 1ЊC). For the ultrafilter cells, 70% of the applied volume was collected (140 ml) to reduce colloid breakthrough [27] . Two individual ultrafilter cells were used to produce approximately 280 ml of the dissolved fraction (Ͻ1 kD), which subsequently was used as the COC diluent. The 1.5-and 0.22-m filters were used only once and discarded. The ultrafilter membranes, which were used a maximum of three times before being replaced, were cleaned between filtering events by flushing with 50 ml of 0.1 N NaOH followed by 100 ml of Milli-Q water and stored in Milli-Q water at 4ЊC.
Sorption procedure
Using Eppendorf pipettes (Westbury, NY, USA), 8 ml of Ͻ1 kD permeate and 4 ml of a specific COC size fraction were combined in borosilicate glass tubes. A total of three glass tubes were used for each COC solution. The E2 (Ͼ98% purity, Sigma Chemical, St. Louis, MO, USA) was spiked to a final concentration of 10 Ϫ7 M in two of the tubes, and the third tube was used as a negative control. Each tube was covered with aluminum foil, capped, tumbled at 30 rpm for 2 min, and allowed to equilibrate for 20 min. This procedure allowed sorption between E2 and COC to reach apparent equilibrium [24] . Fifty-l aliquots from each tube were transferred to 96-well microtiter plates (Linbro/Titertek, ICN Biomedicals, Aurora, OH, USA) for use in the YES bioassay. The entire procedure was repeated two times by adding 4-ml aliquots of the specific COC size fraction to the previously used glass tubes to increase the COC concentration (thereby increasing the total volume from 12 to 16 and from 16 to 20 ml). After each addition, the tubes were mixed, allowed to equilibrate, and aliquoted (50 l) into the 96-well microtiter plate. The same protocol was used for the Ͻ1-kD permeate, which served as the dissolved phase control.
All glassware and equipment used in the sorption procedure was autoclaved (121ЊC for 30 min) to eliminate interferences resulting from microbial contamination.
Recombinant Yeast Estrogen Screen (YES) bioassay
Bioavailability of 17␤-estradiol was determined using the YES bioassay as described previously by Routledge and Sumpter [14] , except for modifications as described below. A recombinant yeast strain containing the hER gene was obtained from J. Sumpter of Brunel University (Middlesex, UK). The strain also contains an expression plasmid carrying the lac-Z reporter gene. When the cells are incubated in the presence of estrogenic compounds, the lac-Z product, ␤-galactosidase, is secreted into the medium and causes the chromogenic substrate, chlorophenol red-␤-D-galactopyranoside (Roche Diagnostics, Indianapolis, IN, USA), to turn red. This color change can be quantified by measuring absorbance (Spectracount Microplate Photometer BS-10,000, Packard, Meriden, CT, USA). In the 96-well microtiter plates, the 50-l aliquots removed from the pre-equilibrated glass tubes were diluted serially in 12 wells using Ͻ1-kD permeate. Ten-l aliquots from each of the serially diluted wells then were transferred, in duplicate, to new wells containing 200 l of growth medium and yeast cells (grown to an absorbance of 1 at 600 nm), and the blend was mixed manually. The plates were incubated at 32ЊC for 3 d and then moved to room temperature for 2 d [28] .
After the total incubation period, dose-response curves were created from absorbance readings taken at 540 nm and 620 nm for each size fraction and at each carbon concentration. Because ␤-galactosidase may be present in the COC solutions as an excretion product from bacteria in the wastewater treatment plant, the results from any E2-spiked sample were discarded if the accompanying negative control had any measurable color change. As a result, unfiltered supernatant and Ͻ1.5-m COC solutions had to be autoclaved prior to use, and the other size fractions (1 kD-0.22 m) could be used without any treatment.
A plate containing standards and control samples was included for every YES bioassay performed and included: Three rows of serially diluted E2 using both Milli-Q water as the diluent (positive control); a row containing negative control samples (Milli-Q only); and a row containing blank samples (growth media only). The concentrations for the E2 serially diluted wells ranged from 12 to 25,000 pM. The standard curve used to determine estradiol-equivalents (E2-Eq) in molar units was determined from the arithmetic mean of the three wells containing the same E2 concentrations.
Analytical and calculation methods
Nonvolatile organic carbon concentrations were measured using a Sievers 800 total organic carbon analyzer (Boulder, CO, USA). Protein was measured using the Frølund et al. [29] modification of the Lowry et al. [30] method. Polysaccharides were measured using the method of Dubois et al. [31] . Protein standards were prepared with bovine serum albumin, and polysaccharide standards were prepared with glucose. Absorbance (at 465 nm) and fluorescence intensity (at excitation/emission of 350 nm/450 nm) measurements, which may be related to humic and fulvic acids concentrations [32] , were quantified by a Beckman DU-640 spectrophotometer (Fullerton, CA, USA) and Perkin-Elmer 650-10S fluorescence spectrophotometer (Wellesley, MA, USA), respectively, using a standard quartz cuvette. The excitation and emission bandwidths both were set at 5 nm in the fluorescence spectrophotometer. Absorbance measurements were taken of the COC solution at 280 nm on the Beckman spectrophotometer. Each organic carbon component was measured in triplicate, and the arithmetic average was used in the analysis.
The COC solution concentrations were calculated by subtracting the dissolved phase (Ͻ1 kD permeate) concentration of a specific analyte (e.g., total organic carbon) from the concentration of a specific size fraction (e.g., Ͻ1.5 m filtrate). Molar extinction coefficients at 280 nm (e 280 ) were calculated by mathematically dividing the absorbance measurements by the COC concentration (in moles/L) for a given solution.
The EC50 values were normalized to account for the large sample quality variability in the dissolved phase (Ͻ1 kD). Normalization was achieved by dividing the EC50 values by the Ͻ1-kD EC50 value (Eqn. 1) and is similar to the procedure used by Versteeg and Shorter [33] . This method assumes that, because the dissolved phase is unable to bind to organic compounds [34] , E2 completely should be bioavailable to the yeast cells. Furthermore, normalizing to the Ͻ1-kD permeate will account for any matrix-specific effect on the yeast cells, such as dissolved chemical inhibition present in the wastewater samples.
(EC50) i, j normalized EC50 value ϭ (1) (EC50) 1, j where i ϭ specific size fraction (unfiltered, Ͻ1.5 m, etc.) and j ϭ COC dilution series (one, two, or three).
Regression and statistical analysis
The previously defined dose-response parameters were determined by best-fit lines using nonlinear, logistical regression (Origin 6.1, Northampton, MA, USA) of corrected absorbance versus E2 concentration corrected absorbance minimum Ϫ maximum ϭ ϩ maximum (2) Outlier analysis of the dose-response curve parameters was performed with the Grubbs test [35] using an alpha value of 0.05 to determine significance. SigmaPlot 6.0 (Chicago, IL, USA) was used for all statistics, hypothesis testing, and linear regression.
RESULTS
Size fractionation
The results of the size fractionation by filtration and ultrafiltration are summarized in Table 1 . As expected, the organic carbon, protein, and polysaccharide concentrations increased with the larger size fractions. The results for the absorption at 465 nm and fluorescence intensities (at 350 nm/450 nm) generally followed this same trend, although some of the smaller size fractions had higher measurable concentrations of these components compared to the larger size fractions (e.g., Ͻ30 kD). The e 280 coefficients for most of the sampling period generally increased with decreasing colloidal size fraction, and the dissolved phase had the lowest values. Variations in the sewage organic load would impact the operating food-to-microorganism ratio (F/M) and, hence, the organic matter composition of the samples. For example, variable F/M ratios would result in different proportions of cell lysis products and growth-associated soluble microbial products in the MLSS supernatant [36] during the different sampling periods.
Dose-response curves: Positive control
Nonlinear regression correlations for dose-response curves were excellent (r 2 Ͼ 0.98) for all samples. The EC50 values of the positive control dose-response curves varied over the course of this investigation, ranging between 39 and 118 pM. The slight differences in E2 sensitivity by the yeast may be attributed to physiological variations in the yeast culture with time, because the EC50 values increased during the course of the investigation. Nevertheless, the average EC50 value for E2 obtained in Milli-Q water was 86 pM and is comparable to values reported by others [19, 21, 28] .
Dose-response curves-experimental. The correlations of the nonlinear regressions for the experimental dose-response curve were excellent (r 2 Ͼ 0.98) for most samples and never below 0.94. Multiple regression analysis demonstrated that the min, max, and slope parameters have a significant effect on the EC50 values and, consequently, the dose-response parameters were screened with the Grubbs test to remove any outliers. The Grubbs test revealed that 11% of the total dataset (16 out of 144 samples) had min, max, or slope parameters that were considered outliers and, therefore, were not considered during the ensuing analysis. Following the outlier analysis, the average min, max, and slope parameters of the doseresponse curves were statistically equivalent between the Milli-Q control and experimental datasets from each COC solution (Table 2) .
A loss of sensitivity to E2 by the yeast culture was observed when the yeast incubation was carried out in the presence of colloidal organic material. Figure 2 illustrates that the doseresponse curve of the experimental reactor containing Ͻ0.22 m colloidal material is shifted to the right compared to the control, resulting in a greater EC50 value. This increase in EC50 values for the experimental dose-response curves relative to the Milli-Q control was universal for all size fractions, including the Ͻ1-kD permeate (Table 2) . A one-sided student's t-test revealed a significant difference (p Յ 0.05) between the EC50 values of the Ͻ1-kD permeate, and the Milli-Q controls and the larger COC size fractions (whole and Ͻ1.5-m samples), respectively ( Table 2 ). By contrast, there was no significant difference (p Ͼ 0.17) between the EC50 values for the Ͻ1-kD permeate and the remaining COC size fractions. These results suggest that material from any size fraction can reduce the sensitivity of the bioassay (compared to the Milli-Q control) but that larger COC size fractions play a more significant role in the observed bioassay response compared to smaller material. Although the general trend of higher EC50 values for the larger size fractions always were observed, there was some variability in EC50 values for the different size fractions during separate sampling events (individual data not shown). The variability in the EC50 values demonstrates the complex nature of the MLSS-derived colloidal and dissolved material.
Influence of colloidal material on normalized EC50 values. Linear regressions between the average normalized EC50 values and the characterized organic components listed in Table  1 were used to determine what component(s) could be used to make a priori estimates of reduced E2 sensitivity by the yeast culture. Linear regressions were performed for colloidal organic carbon (Fig. 3) , protein, and polysaccharide concentrations, as well as absorbance at 465 nm and fluorescence intensity measurements at 350 nm/450 nm, and are summarized in Table 3 . Colloidal organic carbon and polysaccharide concentrations, as well as fluorophore material, had a significant impact (p Ͻ 0.05) on the observed normalized EC50 Table 3 .
values. This suggests that these three components (or, in the case of the fluorescence intensity measurements, the unknown components that fluoresce at this excitation and emission wavelength) have a significant impact on the sensitivity/expression of the YES bioassay. Neither protein concentration nor absorbance measurements at 465 nm significantly influenced the normalized EC50 values ( p Ͼ 0.1).
Comparison between normalized EC50 values and colloidal sorption model
We recently demonstrated that the binding coefficient between E2 and COC in a size-fractionated MLSS-derived colloidal matrix could be estimated by the following equation [24] :
and the distribution of E2 between the dissolved and colloidal phases can be estimated by [37] (COC)(K )
Using the e 280 coefficients and COC concentrations from Table  1 and correcting for dilution, the amount of colloid-associated E2 was estimated with Equations 2 and 3. For our samples, we calculated that between 14 and 30% of the E2 was associated with COC. A linear regression between the normalized EC50 values and the calculated colloid-associated E2 fraction yielded an insignificant slope (p ϭ 0.41) and very weak correlation (r 2 ϭ 0.14; data not shown), suggesting that e 280 coefficients are not an appropriate method for estimating the reduction in YES bioassay response.
DISCUSSION
The increase in EC50 values for a given E2 concentration in the presence of COC may be caused by one or more of the following factors including: Increased toxicity to the yeast culture caused by unknown organic pollutants in the wastewater samples; antiestrogenic (antagonist) activity or inhibition of YES bioassay caused by unknown organic pollutants present in the wastewater samples; interference of the hER binding sites by colloidal material in the wastewater samples; or reduced bioavailability of E2 caused by sorption to colloidal Environ. Toxicol. Chem. 24, 2005 R.D. Holbrook et al. material. Each of these factors is considered in the following discussion.
Increased toxicity
Yeast toxicity can be identified by the presence of clear yellow (or white) microtiter plate wells [28] . In our experiments, we observed a red color in wells containing E2-spiked samples, indicating production of ␤-galactosidase and an opaque yellow color in the wells containing the negative control samples. The red color was reduced in a dose-dependent manner consistent with serial dilutions of an uninhibited bioassay [14, 21] . The yeast density (as indicated by absorbance measurements at 620 nm) of the positive control was not significantly different from the absorbance of the experimental systems (student's t-test, p Ͻ 0.05) for a given yeast culture. Subsequently, the shift in the dose-response curves (i.e., increase in EC50 values) is not consistent with yeast cell toxicity. Furthermore, the presence of a dissolved toxin would have been detected by the Ͻ1-kD fraction and corrected for in the normalization procedure.
Antiestrogenic (antagonist) or inhibitory compounds
The comparatively large binding cavity of the hER makes it susceptible to both activation and inhibition by a wide and structurally diverse set of organic compounds [38, 39] . Antiestrogenic compounds are able to mask the estrogenic potency of other compounds by interfering with the hER, and inhibitory compounds can reduce the sensitivity of the YES bioassay either directly (binding to or modifying the structure of the hER) or indirectly (inhibition of ␤-galactosidase production). Some individual antiestrogenic compounds have been identified and include polyaromatic hydrocarbons, polychlorinated biphenyls, and various phytochemicals [40, 41] . Both antiestrogenic and inhibitory compounds may be present in wastewater effluents [21] and, therefore, potentially could contribute to increased EC50 values of the dose-response curves. Antiestrogenic and/or inhibitory compounds first must be bioavailable to the yeast culture. This can occur if the compounds are present in the dissolved phase (Ͻ1 kD permeate) or, alternatively, are desorbed from the colloidal material during the sorption procedure. Indeed, the significant difference in EC50 values between the Ͻ1-kD permeate and Milli-Q control samples suggests the presence of an antiestrogen/inhibitor. However, the concentration of such a compound in the dissolved phase should be identical in all the samples and, therefore, solely cannot explain the increase of EC50 values observed in the larger COC fractions. Similar to the yeast toxin, the normalization procedure should account for any antiestrogenic or inhibitory compounds present in all samples. Desorption of an antiestrogenic and/or inhibitory compound from the largersized colloidal material is possible and cannot be ruled out completely in the present experiments. However, Conroy et al. [42] recently observed that the presence of antiestrogenic compounds would cause a decrease in the maximum absorbance of a dose-response curve from a YES assay, a phenomenon that we did not observe in our experiments (Table 2) . Consequently, we do not believe that desorption of an antiestrogenic and/or inhibitory compound from the colloidal phase is principally responsible for the observed behavior of the YES assay.
Direct interference of hER by colloidal material
It is possible for colloidal material to bind with the hER and, in effect, become a YES bioassay antagonist. Because the hERs are located intracellularly, colloidal material first would need to be transported across the cell membrane prior to binding with the hER. Macromolecules with molecular weights less than 100 kD are able to pass directly through the cell membrane via diffusion or passive diffusion, although larger molecules first require hydrolysis prior to cell-membrane transport [43] . Subsequently, changes in the dose-response curve due to the antagonistic action of the colloidal material should increase with smaller size fractions. Although direct interference of the hER with smaller colloidal material (Ͻ100 kD) for some samples cannot be ruled out completely, our results indicate that, in general, direct interference of the hER is minor at COC concentrations below 5 mg/L, because EC50 values of the smaller size fractions (Ͻ100 kD) were not statistically different when compared to colloidal-free (Ͻ1 kD) solutions (Table 2 ). However, this direct interference may help explain the large differences in EC50 values that were observed between the Milli-Q control and Ͻ1 kD solution (Table 2) .
Reduction in bioavailability of E2 caused by sorption to colloidal material
The bioavailability and toxic action of organic compounds is intimately related to the presence of and affinity for colloidal organic material. Many investigators have shown reduced toxicity of organic pollutants in the presence of dissolved organic matter derived from natural systems [44, 45] . The presence of colloidal material, whether natural or wastewater-derived, would appear to be most critical for environmental endocrine disruptors because the mechanism of disruption is based on binding (or lack thereof) to specific molecular receptors. Organic contaminants such as E2 that are bound to colloidal Effect of colloids on yeast estrogen screen bioassay Environ. Toxicol. Chem. 24, 2005 2723 material should not be able to interact with the hER due to lack of recognition by the hER for the COC-E2 ligand [11] . The results of this study indicate that an important component in increasing normalized EC50 values (i.e., reducing the sensitivity of the YES bioassay by decreasing the bioavailable fraction of E2) is COC concentration (Fig. 3) . Our results are in agreement with other investigators using conventional in vivo assays (i.e., Daphnia magna) who reported that increasing concentrations of dissolved organic material resulted in a concomitant reduction in the bioavailability of toxic organic compounds [45, 46] . Similarly, Tanghe et al. [11] observed a substantial increase in the EC50 value of a YES bioassay dose-response curve when samples contained both E2 and 150 mg/L of humic acid. Although our samples contained much lower concentrations of COC (1-5 mg/L) compared to the Tanghe et al. [11] study, we did observe statistically significant relationships between colloidal components (namely organic carbon and polysaccharide concentrations and fluorophore material, Table 3 and Fig. 3 ) and normalized EC50 values. We attribute the increase in EC50 values of the doseresponse curves to a reduction in bioavailability of E2 caused by sorption to colloidal organic material.
This experiment also demonstrated that the reduction in E2 bioavailability caused by COC is highly variable for a given size fraction, as illustrated in Figure 3 by the large standard deviations. Such variability may be caused by differences in the composition and character of the colloidal material or from the sample matrix itself. For example, the addition of high ionic strength yeast growth media may alter colloidal morphology [47] , thereby rendering active sites for E2 sorption unavailable. Although binding of E2 to COC occurs byelectron interactions [48] and hydrogen bonding between phenolic groups [48] instead of hydrophobic partitioning, the structural modifications in COC caused by changes in ionic strength could reduce the accessibility of E2 to preferred sorption sites. Additionally, transport of bulk E2 through the yeast's cell membrane may favor desorption of E2 from the colloidal surface to maintain bulk equilibrium, suggesting that the strength of the E2-colloid bond may be important in reducing E2 bioavailability.
To our knowledge, this is the first study that has examined the impact of COC on E2 sensitivity of the YES bioassay. Our method of size fractionation limited the COC concentrations investigated to 1 to 10 mg/L. Although 1 to 10 mg/L of COC may be environmentally relevant for some natural systems, eutrophic freshwater systems, highly productive marine systems, and sample extracts/concentrates may possess higher concentrations of colloidal material that can reduce E2 bioavailability during YES bioassay analysis. Subsequently, our results should be viewed with caution when extrapolating to samples that have a higher concentration of any COC size fraction.
CONCLUSION
Following outlier analysis and normalization, the EC50 values generated by the YES bioassay had significant variability in the presence of wastewater-derived COC. The complexity of the effluent organic matter may cause a portion of this variability. Increases in normalized EC50 values were attributed to reduced E2 bioavailability due to E2 sorption by colloidal material. Consequently, the YES assay may tend to underestimate the concentration of estrogen agonist (i.e., E2) for samples derived from wastewater bioreactors without proper clean-up/fractionation. Statistically significant and moderate linear correlations (p Ͻ 0.05 and r 2 between 0.58 and 0.73) between normalized EC50 values and colloidal organic carbon and polysaccharide concentrations and fluorophore material (measured at 350 nm/450 nm) suggest that these components play the most significant role among colloids in reducing the bioavailability of E2 during the YES bioassay.
